Influenza A virus A/Christchurch/16/2010 NIB-74 (H1N1) antigen (propiolactone inactivated) Terminated Phase 1 Trials for Neoplasm Supportive Care

Indications	Status	Purpose	Phase
DBCOND0017273 (Neoplasm)	Terminated	Supportive Care	1

clinicaltrials.gov Identifier	Title	Drugs
NCT01695733	Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy	Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) (DB10791) Influenza A virus A/Christchurch/16/2010 NIB-74 (H1N1) antigen (propiolactone inactivated) (DB10781) Influenza A virus A/Texas/50/2012 X-223 (H3N2) antigen (propiolactone inactivated) (DB11045) Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) (DB14445) Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) (DB10794) Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (propiolactone inactivated) (DB11046)